499 related articles for article (PubMed ID: 17878107)
1. Physical mechanisms and methods employed in drug delivery to tumors.
Besić E
Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery in cancer using liposomes.
Dass CR
Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
[TBL] [Abstract][Full Text] [Related]
3. Liposomal cancer therapy: exploiting tumor characteristics.
Kaasgaard T; Andresen TL
Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery to tumours: recent strategies.
Reddy LH
J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
[TBL] [Abstract][Full Text] [Related]
5. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
6. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
7. Liposomes in ultrasonic drug and gene delivery.
Huang SL
Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
[TBL] [Abstract][Full Text] [Related]
8. Carbon-based drug delivery carriers for cancer therapy.
Lim DJ; Sim M; Oh L; Lim K; Park H
Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
[TBL] [Abstract][Full Text] [Related]
9. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
11. Tumour-targeted drug and gene delivery: principles and concepts.
Cassidy J; Schätzlein AG
Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for drug delivery in cancer treatment.
Haley B; Frenkel E
Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
[TBL] [Abstract][Full Text] [Related]
13. Magnetically modulated therapeutic systems.
Häfeli UO
Int J Pharm; 2004 Jun; 277(1-2):19-24. PubMed ID: 15158965
[TBL] [Abstract][Full Text] [Related]
14. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
16. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
Ahmed SE; Martins AM; Husseini GA
J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of targeted delivery with pulsed high intensity focused ultrasound.
O'Neill BE; Li KC
Int J Hyperthermia; 2008 Sep; 24(6):506-20. PubMed ID: 18608574
[TBL] [Abstract][Full Text] [Related]
18. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the delivery of cancer drugs that block angiogenesis.
Cao Y; Langer R
Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
[TBL] [Abstract][Full Text] [Related]
20. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
Kaneda Y
Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]